KannaLife Sciences careers

KannaLife Sciences is a bio-pharmaceutical and phyto-medical company involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. KannaLife Sciences currently holds an exclusive license with National Institutes of Health (NIH) for the Commercialization of U.S. Patent #6630507, “Cannabinoids as Antioxidants and Neuroprotectants” (‘507 Patent).

KannaLife is currently conducting research and development at the Bucks County Pennsylvania Biotechnology Center in Doylestown, PA, for a target drug candidate to treat Hepatic Encephalopathy (HE) and Chronic Traumatic Encephalopathy (CTE). HE and CTE, both oxidative stress related diseases that affects the cognitive and behavioral functions, and the wellness of the brain.

KannaLife's ultimate goal is to become a profitable and socially responsible company that seeks to improve the quality of life of patients using plant based natural products.